Literature DB >> 12678920

Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.

Marcelo Campos1, Constance Couture, Izaura Y Hirata, Maria A Juliano, Thomas P Loisel, Philippe Crine, Luiz Juliano, Guy Boileau, Adriana K Carmona.   

Abstract

The PHEX gene (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) encodes a protein (PHEX) with structural homologies to members of the M13 family of zinc metallo-endopeptidases. Mutations in the PHEX gene are responsible for X-linked hypophosphataemia in humans. However, the mechanism by which loss of PHEX function results in the disease phenotype, and the endogenous PHEX substrate(s) remain unknown. In order to study PHEX substrate specificity, combinatorial fluorescent-quenched peptide libraries containing o -aminobenzoic acid (Abz) and 2,4-dinitrophenyl (Dnp) as the donor-acceptor pair were synthesized and tested as PHEX substrates. PHEX showed a strict requirement for acidic amino acid residues (aspartate or glutamate) in S(1)' subsite, with a strong preference for aspartate. Subsites S(2)', S(1) and S(2) exhibited less defined specificity requirements, but the presence of leucine, proline or glycine in P(2)', or valine, isoleucine or histidine in P(1) precluded hydrolysis of the substrate by the enzyme. The peptide Abz-GFSDYK(Dnp)-OH, which contains the most favourable residues in the P(2) to P(2)' positions, was hydrolysed by PHEX at the N-terminus of aspartate with a k(cat)/ K(m) of 167 mM(-1) x s(-1). In addition, using quenched fluorescence peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein sequences flanked by Abz and N -(2,4-dinitrophenyl)ethylenediamine, we showed that these physiologically relevant proteins are potential PHEX substrates. Finally, our results clearly indicate that PHEX does not have neprilysin-like substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678920      PMCID: PMC1223479          DOI: 10.1042/BJ20030287

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.

Authors:  A F Ruchon; H S Tenenhouse; M Marcinkiewicz; G Siegfried; J E Aubin; L DesGroseillers; P Crine; G Boileau
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

2.  Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin.

Authors:  B J Backes; J L Harris; F Leonetti; C S Craik; J A Ellman
Journal:  Nat Biotechnol       Date:  2000-02       Impact factor: 54.908

3.  Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11.

Authors:  A J Trapani; S De Lombaert; S Kuzmich; A Y Jeng
Journal:  J Cardiovasc Pharmacol       Date:  1995       Impact factor: 3.105

4.  Neprilysin II: A putative novel metalloprotease and its isoforms in CNS and testis.

Authors:  T Ouimet; P Facchinetti; C Rose; M C Bonhomme; C Gros; J C Schwartz; O Tanja
Journal:  Biochem Biophys Res Commun       Date:  2000-05-19       Impact factor: 3.575

5.  Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme.

Authors:  M C Araujo; R L Melo; M H Cesari; M A Juliano; L Juliano; A K Carmona
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

6.  MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.

Authors:  P S Rowe; P A de Zoysa; R Dong; H R Wang; K E White; M J Econs; C L Oudet
Journal:  Genomics       Date:  2000-07-01       Impact factor: 5.736

7.  Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers.

Authors:  S Kiryu-Seo; M Sasaki; H Yokohama; S Nakagomi; T Hirayama; S Aoki; K Wada; H Kiyama
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

8.  Organization and chromosomal localization of the human ECEL1 (XCE) gene encoding a zinc metallopeptidase involved in the nervous control of respiration.

Authors:  O Valdenaire; E Rohrbacher; A Langeveld; A Schweizer; C Meijers
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

9.  Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries.

Authors:  J L Harris; B J Backes; F Leonetti; S Mahrus; J A Ellman; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

10.  cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone.

Authors:  L Du; M Desbarats; J Viel; F H Glorieux; C Cawthorn; B Ecarot
Journal:  Genomics       Date:  1996-08-15       Impact factor: 5.736

View more
  28 in total

Review 1.  Role of prostaglandins in the pathogenesis of X-linked hypophosphatemia.

Authors:  Michel Baum; Ashu Syal; Raymond Quigley; Mouin Seikaly
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

Review 2.  Endocrine functions of bone in mineral metabolism regulation.

Authors:  L Darryl Quarles
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

3.  Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.

Authors:  Shiguang Liu; Peter S N Rowe; Luke Vierthaler; Jianping Zhou; L Darryl Quarles
Journal:  J Endocrinol       Date:  2007-01       Impact factor: 4.286

Review 4.  Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis.

Authors:  Aline Martin; L Darryl Quarles
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

5.  Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).

Authors:  Peter S N Rowe; Ian R Garrett; Patricia M Schwarz; David L Carnes; Eileen M Lafer; Gregory R Mundy; Gloria E Gutierrez
Journal:  Bone       Date:  2004-11-24       Impact factor: 4.398

6.  ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.

Authors:  Valentin David; Aline Martin; Anne-Marie Hedge; Marc K Drezner; Peter S N Rowe
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-22

Review 7.  Regulation and function of the FGF23/klotho endocrine pathways.

Authors:  Aline Martin; Valentin David; L Darryl Quarles
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

8.  Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

Authors:  Despina Sitara; Mohammed S Razzaque; Martina Hesse; Subbiah Yoganathan; Takashi Taguchi; Reinhold G Erben; Harald Jüppner; Beate Lanske
Journal:  Matrix Biol       Date:  2004-11       Impact factor: 11.583

9.  Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

Authors:  Aline Martin; Valentin David; Jennifer S Laurence; Patricia M Schwarz; Eileen M Lafer; Anne-Marie Hedge; Peter S N Rowe
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

Review 10.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.